Serbin Creative, Inc.

(805) 963-0439 | Toll-Free (800) 876-6425

www.serbincreative.com LA / NY / UK

Daclizumab— Blockage of dendritic cell receptor 

Prev Next
Previous

Removal of inguinal lymph packet

illustration of Part of a series; E-learning and booth graphics for therapeutic monoclonal antibody Daclizumab (Zenapax®) — Showing blockage of IL-2 receptor target.

Drug's mechanism of action graphics at cellular level for pharmaceutical project.

Keywords: molecular biology, cellular biology, histology, pharmacology, virology, disease management; multiple sclerosis
Next illustration of Image to accompany printed article: showing phosphorylation of GltX by bacterial toxin HipA, which blocks GltX from adding amino acid to tRNA. The uncharged tRNA halt protein synthesis and subsequently shut down cellular activity

Bacterial Persisters

Part of a series; E-learning and booth graphics for therapeutic monoclonal antibody Daclizumab (Zenapax®) — Showing blockage of IL-2 receptor target. Drug's mechanism of action graphics at cellular level for pharmaceutical project. Keywords: molecular biology, cellular biology, histology, pharmacology, virology, disease management; multiple sclerosis

Keywords: Vector, e-Learning, Education, Health, Landscape, Medical, Product, Science, Scientific, Branding

© Mica Duran